Type
GLP-1 receptor agonist.
Medication guide
Wegovy is a semaglutide medicine developed for weight management in eligible adults. It should be considered only after medical review.
Overview
Eligibility, dosing, side effects, and maintenance should be reviewed alongside food habits, strength training, sleep, and metabolic markers.
GLP-1 receptor agonist.
Chronic weight management where appropriate.
Coach and clinician follow-up.
Program fit
Start with an intake and doctor review.
Start assessment